GO:0030330 DNA damage response, signal transduction by p53 class mediator: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030330 describes the p53-class mediator signaling cascade that converts DNA damage detection into transcriptional and cell-fate decisions.
• The pathway is defined by p53/TP53 activation and downstream effectors such as p21, and it coordinates cell cycle arrest, DNA repair, senescence, or apoptosis.
• 53BP1 is a key chromatin-associated mediator that influences double-strand break repair pathway choice and is frequently studied in this response.
• Dysregulation of this pathway is central to cancer biology, chemotherapy response, and resistance phenotypes in multiple tumor types.
• Environmental and therapeutic DNA-damaging agents, including doxorubicin, ochratoxin A, ionizing radiation, and bortezomib, are used to activate and study this response.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of p53-pathway components in isogenic backgrounds.
Description
GO:0030330, DNA damage response, signal transduction by p53 class mediator, is a biological process that defines the cascade through which the cell cycle regulator p53, or an equivalent protein, transmits signals after DNA damage is detected. This term captures the signaling steps that link damage sensors to p53-class mediator activation and to downstream transcriptional programs that determine whether a cell arrests, repairs, senesces, or dies. Because p53-class signaling is a central node in genome maintenance, it is one of the most intensively studied processes in cancer biology, toxicology, and radiation biology.
DNA damage response, signal transduction by p53 class mediator At A Glance
| GO ID | GO:0030330 |
|---|---|
| GO term | DNA damage response, signal transduction by p53 class mediator |
| Ontology | biological_process |
| Synonym | DNA damage response, activation of p53; p53-mediated DNA damage response; p53 signaling pathway; TP53 signaling pathway |
| Major function | Transduces DNA damage signals through p53-class mediators to regulate cell cycle checkpoints, DNA repair, senescence, and apoptosis |
| Key mediators | TP53, CDKN1A (p21), 53BP1 (TP53BP1), and associated checkpoint and repair factors |
| Representative triggers | Doxorubicin, ochratoxin A, ionizing radiation, and bortezomib-induced DNA damage |
| Disease relevance | Cancer, chemotherapy response, and resistance phenotypes in multiple myeloma and other tumors |
What Is GO:0030330?
In practical terms, GO:0030330 is the p53-mediated DNA damage response signaling pathway. It begins when DNA lesions are recognized and converted into signals that activate p53 or an equivalent mediator protein, which then propagates the signal to downstream effectors that control cell cycle checkpoints, DNA repair, senescence, and apoptosis. The term is not limited to a single gene; it encompasses the signal transduction cascade by which p53-class mediators coordinate the cellular response to DNA damage.
Why Is DNA damage response, signal transduction by p53 class mediator Important in Cell Biology?
GO:0030330 is important because it defines the signaling logic by which cells interpret DNA damage and choose between survival and elimination. This decision directly affects tumor suppression, the efficacy of DNA-damaging chemotherapy and radiotherapy, and the emergence of resistance. Experimental work in ovarian, gastric, and hematopoietic models shows that p53-class signaling is a measurable and modifiable axis of the DNA damage response.
• Defines the p53-class mediator cascade that converts DNA damage into cell-fate decisions.
• Controls cell cycle arrest through effectors such as p21 after genotoxic stress.
• Influences double-strand break repair pathway choice via 53BP1 and related factors.
• Determines sensitivity or resistance to DNA-damaging agents such as doxorubicin and bortezomib.
• Is activated by environmental and dietary genotoxins such as ochratoxin A.
• Is studied in radiation biology, including combined ionizing radiation and simulated microgravity exposures.
• Provides mechanistic biomarkers for chemotherapy response in multiple myeloma.
• Supports functional genomics screens that map p53-pathway dependencies.
• Enables isogenic CRISPR models to test causality of individual pathway components.
• Connects DNA repair, checkpoint control, and apoptosis into a single ontology-defined process.
What Happens During DNA damage response, signal transduction by p53 class mediator?
DNA damage detection and signal initiation
In simple terms: First, the cell notices that its DNA is broken or chemically altered.
The process begins when DNA lesions are detected after exposure to genotoxic agents such as doxorubicin, ochratoxin A, ionizing radiation, or bortezomib. Damage detection generates the initial signals that feed into the p53-class mediator cascade, setting the stage for downstream checkpoint and repair responses.
Activation of p53-class mediators
In simple terms: The damage signal switches on p53 or an equivalent mediator protein.
Once damage is sensed, p53-class mediators become activated and propagate the signal. In experimental systems, this activation is linked to downstream transcriptional responses and to cell cycle effects such as G2 phase arrest. The mediator layer integrates damage signals with chromatin-associated factors, including 53BP1, that influence how the break is processed.
Downstream effector programs: arrest, repair, senescence, and apoptosis
In simple terms: The activated signal then tells the cell to pause, repair, or self-destruct.
Activated p53-class signaling drives effector programs that include cell cycle checkpoint arrest and DNA repair. In human gastric epithelium cells, ochratoxin A-induced DNA damage triggers G2 phase arrest via an hMLH1-p53-p21 signaling axis. In parallel, 53BP1-dependent processes shape the repair of radiation-induced double-strand breaks. These effector outputs determine whether the cell survives with repaired DNA or is eliminated.
Integration with repair pathway choice
In simple terms: The signal also helps decide which repair method the cell will use.
The p53-class mediator response is functionally coupled to double-strand break repair pathway choice. 53BP1 is a central chromatin-associated factor in this decision and has been extensively characterized in the repair of radiation-induced DNA double-strand breaks. This integration ensures that checkpoint signaling and repair execution are coordinated rather than independent.
Cell-fate resolution and experimental readouts
In simple terms: Finally, the cell commits to a fate that researchers can measure.
The pathway resolves into measurable outcomes such as arrest, repair, senescence, or apoptosis. Experimental models use DNA-damaging exposures and readouts of p53-pathway activity to quantify these outcomes. In ovarian models, AMH protects against doxorubicin by regulating cell fate and the response to DNA damage, illustrating how the pathway can be modulated.
Key Genes Involved in GO:0030330 DNA damage response, signal transduction by p53 class mediator
The following genes and proteins are experimentally and mechanistically associated with GO:0030330 and its DNA damage response context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Central p53-class mediator that transduces DNA damage signals | Core node for functional studies of GO:0030330 |
| CDKN1A (p21) | Downstream effector mediating cell cycle arrest | Readout of p53-pathway activation after genotoxic stress |
| TP53BP1 (53BP1) | Chromatin-associated mediator influencing double-strand break repair | Key factor in repair pathway choice and radiation response |
| HIC1 | Transcription factor studied in DNA damage-related regulatory networks | Computational and functional analyses of sequence variants |
| MLH1 (hMLH1) | Mismatch repair factor linked to p53-p21 signaling after damage | Component of the hMLH1-p53-p21 axis in gastric epithelium |
| AMH | Modulates cell fate and DNA damage response in ovarian models | Protective factor against doxorubicin-induced damage |
| RAD51 | Homologous recombination repair factor | Repair pathway context for p53-class signaling |
| BRCA1 | Repair and checkpoint-associated factor | Pathway-choice context with 53BP1 |
| ATM | Damage sensor kinase upstream of p53-class signaling | Upstream activation context |
| ATR | Replication stress and damage sensor kinase | Upstream signaling context |
| CHEK2 | Checkpoint kinase in damage signaling | Checkpoint effector context |
| MDM2 | Negative regulator of p53 stability | Regulatory node of p53-class signaling |
| BAX | Apoptotic effector downstream of p53 | Cell-fate outcome readout |
| BBC3 (PUMA) | Apoptotic effector downstream of p53 | Cell-fate outcome readout |
| GADD45A | Growth arrest and DNA damage response factor | Checkpoint and repair context |
| XPC | Nucleotide excision repair factor | DNA damage response context |
| DDB2 | Damage recognition factor in nucleotide excision repair | DNA damage response context |
How Is DNA damage response, signal transduction by p53 class mediator Regulated?
GO:0030330 is regulated at multiple levels. Upstream damage sensors and checkpoint kinases initiate the signal, while MDM2-dependent control of p53 stability provides a negative regulatory layer. Chromatin-associated factors such as 53BP1 modulate how the signal is coupled to repair pathway choice. In addition, external modulators can shift the response: AMH protects ovarian cells from doxorubicin by regulating cell fate and the DNA damage response, and combined exposures such as ionizing radiation with simulated microgravity alter gene expression programs relevant to damage signaling.
DNA damage response, signal transduction by p53 class mediator and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer and chemotherapy response | TP53 knockout and point-mutation isogenic cell lines |
| CDKN1A (p21) | Cell cycle arrest after genotoxic stress | CDKN1A knockout with p21 expression readout |
| TP53BP1 (53BP1) | Double-strand break repair and radiation response | 53BP1 knockout with radiation and repair assays |
| MLH1 (hMLH1) | Gastric epithelium DNA damage response | hMLH1-p53-p21 axis perturbation in gastric cells |
| AMH | Ovarian protection from doxorubicin | AMH overexpression or knockout in ovarian models |
Cancer and chemotherapy response
GO:0030330 is central to cancer biology because p53-class signaling determines whether damaged cells arrest, repair, or die. In multiple myeloma, molecular determinants of bortezomib sensitivity and resistance include DNA damage response and p53-pathway components. In ovarian models, AMH modulates doxorubicin-induced DNA damage responses and cell fate, linking pathway regulation to chemoprotection.
Gastrointestinal toxicity and genotoxin exposure
Environmental and dietary genotoxins can activate the pathway in gastrointestinal epithelium. Ochratoxin A-induced DNA damage triggers G2 phase arrest via an hMLH1-p53-p21 signaling pathway in human gastric epithelium immortalized cells, directly connecting GO:0030330 to a measurable toxicological outcome.
Radiation exposure and genome maintenance
Radiation-induced DNA double-strand breaks engage 53BP1-dependent repair processes that are functionally integrated with p53-class signaling. Studies of ionizing radiation combined with simulated microgravity show differential gene expression in human fibroblasts, providing a model for how environmental stressors reshape damage-response programs.
Genetic variation and regulatory networks
Computational analysis of single nucleotide polymorphisms in the human HIC1 gene highlights how sequence variation in DNA damage-related regulatory factors can be prioritized for functional follow-up. Such analyses complement experimental dissection of GO:0030330 components.
From DNA damage response, signal transduction by p53 class mediator-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TP53 required for damage-induced arrest? | TP53 knockout cell line |
| Does a p53 point mutation alter effector activation? | TP53 point-mutation knock-in |
| How does 53BP1 loss affect repair pathway choice? | 53BP1 knockout with radiation |
| Can AMH protect ovarian cells from doxorubicin? | AMH overexpression in ovarian models |
| Does HIC1 variation affect damage signaling? | HIC1 point-mutation or knockout models |
| What genes change after combined radiation and microgravity? | Transcriptomic profiling of exposed fibroblasts |
How to Study the DNA damage response, signal transduction by p53 class mediator Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Differential gene expression after damage | Radiation and microgravity exposure studies |
| Cell cycle analysis | G2 phase arrest and checkpoint activation | Genotoxin response studies |
| p21 expression assay | Downstream p53-pathway activation | hMLH1-p53-p21 axis readout |
| DNA repair foci imaging | 53BP1-associated repair processes | Radiation-induced double-strand break studies |
| CRISPR knockout screening | Causal requirement of pathway genes | Functional genomics of damage response |
| Computational SNP analysis | Variant prioritization in damage-related genes | HIC1 variant analysis |
| Chemosensitivity assays | Sensitivity or resistance to DNA-damaging drugs | Multiple myeloma and ovarian models |
Transcriptomic profiling of damage responses
RNA sequencing and differential gene expression analysis are used to capture pathway-wide changes after DNA-damaging exposures. Human fibroblasts simultaneously exposed to ionizing radiation and simulated microgravity show differential gene expression that can be mapped to damage-response programs.
Targeted signaling readouts
Quantitative assays of p53-pathway activation, including p21 induction and cell cycle phase analysis, are used to measure GO:0030330 activity. Ochratoxin A-induced G2 phase arrest via the hMLH1-p53-p21 axis provides a concrete example of such readouts.
DNA repair and damage foci assays
Repair-focused assays, including analysis of double-strand break repair and 53BP1-associated processes, are used to connect signaling to repair outcomes. These methods are commonly applied in radiation biology studies.
Functional genomics and computational variant analysis
CRISPR-based functional screens and computational analyses of sequence variants help prioritize pathway components. Computational analysis of HIC1 single nucleotide polymorphisms illustrates how in silico prioritization can guide experimental work on DNA damage-related factors.
How CRISPR Can Be Used to Study GO:0030330 DNA damage response, signal transduction by p53 class mediator
Knockout
CRISPR knockout of TP53, CDKN1A, or TP53BP1 enables loss-of-function tests of GO:0030330 components. Knockout models are used to determine whether a gene is required for damage-induced arrest, repair, or cell-fate outcomes.
Point Mutation
Point-mutation knock-in can model specific TP53 variants or other pathway alleles to test how single amino acid changes alter signaling. Such models are relevant to chemotherapy response and resistance studies.
Knock-in
Tagged or reporter knock-in at pathway loci allows tracking of protein localization, stability, and interaction dynamics during the DNA damage response. These approaches complement repair-foci imaging of 53BP1-associated processes.
Overexpression
Overexpression models, such as AMH overexpression in ovarian systems, test whether increasing a pathway modulator changes cell fate after DNA damage. Overexpression can also be used to probe downstream effector programs.
How EDITGENE Supports DNA damage response, signal transduction by p53 class mediator Research
Researchers studying DNA damage response, signal transduction by p53 class mediator-related genes often need to determine whether a candidate gene is causally involved in damage sensing, signal propagation, or cell-fate resolution. Isogenic CRISPR models provide the controlled backgrounds required to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for DNA damage response, signal transduction by p53 class mediator research.
Frequently Asked Questions About DNA damage response, signal transduction by p53 class mediator
What is GO:0030330?
GO:0030330 is the biological process DNA damage response, signal transduction by p53 class mediator, which defines the cascade through which p53 or an equivalent protein transmits DNA damage signals.
What does DNA damage response, signal transduction by p53 class mediator mean?
It means the p53-mediated signaling pathway that converts DNA damage detection into downstream responses such as cell cycle arrest, repair, senescence, or apoptosis.
What genes are involved in GO:0030330?
Key genes include TP53, CDKN1A (p21), TP53BP1 (53BP1), MLH1, and modulators such as AMH, with additional repair and checkpoint factors contributing to the response.
How is p53 activated after DNA damage?
DNA damage detection generates signals that activate p53-class mediators, which then propagate the response to downstream effectors.
What is the role of 53BP1 in the p53 DNA damage response?
53BP1 is a chromatin-associated mediator that influences double-strand break repair pathway choice and the repair of radiation-induced breaks.
Which diseases are linked to p53-mediated DNA damage signaling?
Cancer and chemotherapy response are strongly linked, including bortezomib sensitivity and resistance in multiple myeloma, as well as genotoxin-induced gastrointestinal effects.
How do researchers study GO:0030330?
Researchers use RNA sequencing, cell cycle analysis, p21 readouts, DNA repair foci imaging, CRISPR screens, and computational variant analysis.
What triggers the p53 DNA damage response in experiments?
Common triggers include doxorubicin, ochratoxin A, ionizing radiation, and bortezomib.
Can CRISPR knockout models be used to study p53 signaling?
Yes, CRISPR knockout of TP53, CDKN1A, or TP53BP1 is used to test requirement and causality in the damage response.
Why is GO:0030330 important for cancer research?
Because p53-class signaling determines whether damaged cells survive or die, it directly affects tumor suppression and chemotherapy outcomes.
Conclusion
GO:0030330 provides a precise ontology framework for the p53-class mediator signaling cascade that links DNA damage detection to cell-fate decisions. Its components, including TP53, CDKN1A, and TP53BP1, are experimentally tractable and clinically relevant across cancer, toxicology, and radiation biology. Isogenic CRISPR models and functional genomics approaches make it possible to test causality within this pathway and to identify modulators of damage sensitivity.
References
- 1. Nguyen NMP et al.. 2025. AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage.. Proc Natl Acad Sci U S A 122(5):e2414734122 PMID: 39874288
- 2. Panier S et al.. 2014. Double-strand break repair: 53BP1 comes into focus.. Nat Rev Mol Cell Biol 15(1):7-18 PMID: 24326623
- 3. Jia X et al.. 2024. Ochratoxin A-induced DNA damage triggers G(2) phase arrest via hMLH1-p53-p21 signaling pathway in human gastric epithelium immortalized cells in vitro.. Toxicol Lett 400:42-48 PMID: 39117293
- 4. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
- 5. Roche KC et al.. 2007. An investigation into 53BP1 complex formation.. Adv Exp Med Biol 604:47-57 PMID: 17695720
- 6. Shibata A et al.. 2020. Roles for 53BP1 in the repair of radiation-induced DNA double strand breaks.. DNA Repair (Amst) 93:102915 PMID: 33087281
- 7. Hossain J et al.. 2026. Molecular determinants of Bortezomib sensitivity and resistance in multiple myeloma.. Cancer Treat Res Commun 48:101303 PMID: 42398468
- 8. Malatesta P et al.. 2024. Differential Gene Expression in Human Fibroblasts Simultaneously Exposed to Ionizing Radiation and Simulated Microgravity.. Biomolecules 14(1) PMID: 38254688
